Moreover, the presence of excess RANKL in vivo can reverse the effects of OPG on TRAIL-induced apoptosis in human breast cancer cells, even though OPG binds to TRAIL and RANKL with the same affinity as in vitro [28]. This evidence concerns the gene TNFSF11 and breast carcinoma.